Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00033635
DRKS00033635
Completed
Not Applicable

Potentially inadequate medication in patients with myasthenia gravis - PIM in Myasthenia gravis

niversitätsmedizin Göttingen0 sites85 target enrollmentFebruary 16, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG70.0Myasthenia gravis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G70.0
Sponsor
niversitätsmedizin Göttingen
Enrollment
85
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 16, 2024
End Date
May 8, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsmedizin Göttingen

Eligibility Criteria

Inclusion Criteria

  • •Patients with clinically and instrumentally verified MG
  • •\- \= 18 years of age
  • •\- Ability to consent or legal guardian with court authorisation for the area of responsibility

Exclusion Criteria

  • •\- Patients with unclear neuromuscular disease without the fulfilment of clinically and clinically and instrumentally definitive signs of MG
  • •\- \<18 years of age
  • •\- Patient incapable of giving consent with a carer, without judicial authorisation for the area of responsibility

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Potentially inappropriate medication according to the PRISCUS2.0 list: Inpatient sample regarding alternative drugs and the reasons for prescriptiomedication in older patients
DRKS00033602Malteser Waldkrankenhaus St. Marien Erlangen, Geriatrie-Zentrum300
Not yet recruiting
Not Applicable
Should a patient with a clinically suspected scaphoid fracture be treated with a cast?clinical suspected scaphoid fracture. Klinische verdenking scaphoid fractuur
NL-OMON20183Erasmus MC180
Active, not recruiting
Not Applicable
Study on patients with moderate, active Crohn’s disease treated with Rifaximin-EIR 400 mg tablets.
EUCTR2011-002821-24-ITALFA WASSERMA
Completed
Not Applicable
Potentially inappropriate medication and risk of serious adverse events in elderly persons - results from the getABI studythe impact of PIM-intake on the combined endpoint: multiple falls, hospitalisation or deathI70.20
DRKS00014098Ruhr-Universität Bochum6,880
Not yet recruiting
Not Applicable
what percentage of elderly cancer patients are on inappropriate medicationsHealth Condition 1: C00-D49- Neoplasms
CTRI/2019/04/018684Tata Memorial Hospital Mumbai